<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Consequently, the drug is poorly absorbed (20–50%) from the GIT and has a low bioavailability from oral formulations [
 <xref rid="B37-molecules-24-02155" ref-type="bibr" class="xref">37</xref>]. Several semisynthetic compounds have been designed to overcome the drawback of very low water solubility such as, e.g., the bis-hemisuccinate (Legalon
 <sup class="sup">®</sup>), 23-
 <italic class="italic">O</italic>-phosphate, 23-
 <italic class="italic">O</italic>-β-glycosides derivatives, silybinic acid and the complex with the excipient amino-sugar meglumine [
 <xref rid="B38-molecules-24-02155" ref-type="bibr" class="xref">38</xref>,
 <xref rid="B39-molecules-24-02155" ref-type="bibr" class="xref">39</xref>]. However, chemical modifications leading to an increase in silybin water-solubility usually led to an impairment of its antioxidant (antiradical) activity [
 <xref rid="B31-molecules-24-02155" ref-type="bibr" class="xref">31</xref>].
</p>
